We did not observe associations between ZEB1 and other clinical parameters such as tumor stage, nodal stage, HER2 status, hormone receptor status, histological type, localization of metastasis, or therapies (chemo‐, hormone‐, radio‐, or herceptin therapy) (all P > 0.1) (Table 4). The gene discussed is ERBB2; the disease is neoplasm.